Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Clinical trial NCT00299390 · TERMINATED

Trial details

NCT number: NCT00299390
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Carcinoma

Start date: 2006-04-01
Primary completion: 2007-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.